Literature DB >> 7426310

Control of cell proliferation in human glioma by glucocorticoids.

R I Freshney, A Sherry, M Hassanzadah, M Freshney, P Crilly, D Morgan.   

Abstract

Survival and proliferation of cell cultures from human anaplastic astrocytomas were shown to be enhanced by glucocorticoids with an optimal concentration of approximately 2.5 x 10(-5)M (10 micrograms/ml). The stimulation of proliferation was only observed in a clonal growth assay and was reversed as the size of individual colonies reached approximately 50 cells. Above this size, and in regular monolayer cultures, glucocorticoids were found to inhibit cell proliferation as measured by direct cell counting and incorporation of [3H] thymidine. Cultures grown to maximum cell densities in non-limiting medium conditions reached a lower terminal cell density, and had a reduced labelling index with [3H] thymidine in the presence of glucocorticoids. Although there was little difference between the actions of beta-methasone, dexamethasone and ethyl prednisolone, methyl prednisolone was found to be more effective, both in terms of stimulation of clonal growth and inhibition of growth at high cell densities. There was no evidence of cytotoxicity with glucocorticoids up to 5 x 10(-5)M (20 micrograms/ml) and it is suggested that glucocorticoids act via a normal regulatory process, perhaps enhancing cell-cell recognition.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426310      PMCID: PMC2010353          DOI: 10.1038/bjc.1980.161

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.

Authors:  S C Seifert; T D Gelehrter
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

2.  Studies on glucocorticoid-induced cytolysis in cultured mouse lymphoma cells, L5178Y. I. Glucocorticoid specificity and cytoplasmic receptors in sensitive and resistant cells.

Authors:  H Kondo; A Kikuta; T Noumura
Journal:  Exp Cell Res       Date:  1975-02       Impact factor: 3.905

3.  Dexamethasone-induced accumulation of a fibronectin and collagen extracellular matrix in transformed human cells.

Authors:  L T Furcht; D F Mosher; G Wendelschafer-Crabb; P A Woodbridge; J M Foidart
Journal:  Nature       Date:  1979-02-01       Impact factor: 49.962

4.  Glucocorticoid-induced growth inhibition of cells from a human lung alveolar cell carcinoma.

Authors:  K L Jones; N S Anderson; J Addison
Journal:  Cancer Res       Date:  1978-06       Impact factor: 12.701

5.  Effects of dexamethasone and methylprednisolone on cell cultures of human glioblastomas.

Authors:  J Mealey; T T Chen; G P Schanz
Journal:  J Neurosurg       Date:  1971-03       Impact factor: 5.115

6.  Hormone induced modification of the cell surface.

Authors:  P L Ballard; G M Tomkins
Journal:  Nature       Date:  1969-10-25       Impact factor: 49.962

7.  Mitomycin C treated cells as feeders.

Authors:  I Macpherson; A Bryden
Journal:  Exp Cell Res       Date:  1971-11       Impact factor: 3.905

8.  Dexamethasone-induced adhesion in hepatoma cells: the role of plasminogen activator.

Authors:  B L Fredin; S C Seifert; T D Gelehrter
Journal:  Nature       Date:  1979-01-25       Impact factor: 49.962

9.  Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors.

Authors:  P G Braunschweiger; J J Stragand; L M Schiffer
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

10.  Effects of dexamethasone and betamethasone on in vitro cultures from human astrocytoma.

Authors:  M Guner; R I Freshney; D Morgan; M G Freshney; D G Thomas; D I Graham
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640

View more
  11 in total

1.  Failure of betamethasone to alter the radiation response of two cultured human glioma cell-lines.

Authors:  G Benediktsson; E Blomquist; J Carlsson
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

2.  Glucocorticoid receptors in glioblastoma multiforme: a new approach to antineoplastic glucocorticoid therapy.

Authors:  K Ellemann; L Christensen; F Gjerris; P Briand; C Kruse-Larsen
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

3.  Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone.

Authors:  B Kaup; I Schindler; H Knüpfer; A Schlenzka; R Preiss; M M Knüpfer
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

4.  Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation.

Authors:  K L Crossin; M H Tai; L A Krushel; V P Mauro; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 5.  Hormesis and medicine.

Authors:  Edward J Calabrese
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

Review 6.  Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy.

Authors:  Sherice Williams; Chaitali Ghosh
Journal:  Drug Discov Today       Date:  2019-09-18       Impact factor: 7.851

Review 7.  The risks and benefits of corticosteroids in advanced cancer.

Authors:  R Twycross
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

8.  Dexamethasone effects on vascular volume and tissue hematocrit in experimental RG-2 gliomas and adjacent brain.

Authors:  H Nakagawa; D R Groothuis; E S Owens; C S Patlak; K D Pettigrew; R R Glasberg
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130

9.  Glial glucocorticoid receptors in aged Fisher 344 (F344) and F344/Brown Norway rats.

Authors:  J Kasckow; C Xiao; J P Herman
Journal:  Exp Gerontol       Date:  2009-02-26       Impact factor: 4.032

10.  Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.

Authors:  A Neshasteh-Riz; R J Mairs; W J Angerson; P D Stanton; J R Reeves; R Rampling; J Owens; T E Wheldon
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.